Related Experiment Video
Updated: May 22, 2026
Capsular Serotyping of Streptococcus pneumoniae Using the Quellung Reaction
Published on: February 24, 2014
Sequetyping: serotyping Streptococcus pneumoniae by a single PCR sequencing strategy
Marcus H Leung1, Kevin Bryson, Kathrin Freystatter
1Centre for Clinical Microbiology, University College London Medical School, Royal Free Campus, London, United Kingdom.
Abstract:
The introduction of pneumococcal conjugate vaccines necessitates continued monitoring of circulating strains to assess vaccine efficacy and replacement serotypes. Conventional serological methods are costly, labor-intensive, and prone to misidentification, while current DNA-based methods have limited serotype coverage requiring multiple PCR primers. In this study, a computer algorithm was developed to interrogate the capsulation locus (cps) of vaccine serotypes to locate primer pairs in conserved regions that border variable regions and could differentiate between serotypes. In silico analysis of cps from 92 serotypes indicated that a primer pair spanning the regulatory gene cpsB could putatively amplify 84 serotypes and differentiate 46. This primer set was specific to Streptococcus pneumoniae, with no amplification observed for other species, including S. mitis, S. oralis, and S. pseudopneumoniae. One hundred thirty-eight pneumococcal strains covering 48 serotypes were tested. Of 23 vaccine serotypes included in the study, most (19/22, 86%) were identified correctly at least to the serogroup level, including all of the 13-valent conjugate vaccine and other replacement serotypes. Reproducibility was demonstrated by the correct sequetyping of different strains of a serotype. This novel sequence-based method employing a single PCR primer pair is cost-effective and simple. Furthermore, it has the potential to identify new serotypes that may evolve in the future.
Insights
A new sequence-based method uses a single PCR primer pair to identify Streptococcus pneumoniae serotypes. This cost-effective approach aids in monitoring vaccine efficacy and detecting emerging strains.
Area of Science:
- Microbiology
- Vaccinology
- Bioinformatics
Background:
- Pneumococcal conjugate vaccines require ongoing surveillance of circulating strains to evaluate efficacy and identify replacement serotypes.
- Traditional serological methods for identifying Streptococcus pneumoniae are inefficient and error-prone.
- Existing DNA-based methods have limited serotype coverage, necessitating multiple polymerase chain reaction (PCR) primers.
Purpose of the Study:
- To develop a novel, cost-effective, and simple sequence-based method for identifying Streptococcus pneumoniae serotypes.
- To design a single PCR primer pair capable of differentiating between pneumococcal serotypes by targeting conserved regions of the capsulation locus (cps).
Main Methods:
- A computer algorithm was employed to analyze the cps of 92 vaccine serotypes, identifying primer pairs within conserved regions flanking variable regions.
- In silico analysis predicted a primer pair spanning the cpsB gene could amplify 84 serotypes and differentiate 46.
- The primer set's specificity was confirmed against other bacterial species, and its performance was evaluated using 138 pneumococcal strains covering 48 serotypes.
Main Results:
- The developed primer set demonstrated specificity for Streptococcus pneumoniae, with no amplification in related species like S. mitis, S. oralis, and S. pseudopneumoniae.
- In silico analysis suggested potential amplification of 84 serotypes and differentiation of 46 using a single primer pair targeting cpsB.
- Experimental testing showed successful identification of 19 out of 22 vaccine serotypes (86%) to at least the serogroup level, including key 13-valent conjugate vaccine and replacement serotypes.
Conclusions:
- A novel, sequence-based method utilizing a single PCR primer pair offers a cost-effective and simple approach for identifying Streptococcus pneumoniae serotypes.
- This method accurately identifies most vaccine serotypes and has the potential to monitor vaccine efficacy and detect emerging or novel serotypes.
- The approach demonstrates reproducibility and specificity, making it a valuable tool for ongoing pneumococcal surveillance.
